XML 20 R8.htm IDEA: XBRL DOCUMENT
v3.25.0.1

EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY | 9 Months Ended
--- | ---
Dec. 31, 2024
LOSS PER SHARE AND STOCKHOLDERS’ EQUITY [Abstract] |
EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY | 2. EARNINGS PER SHARE AND STOCKHOLDERS’ EQUITY: Earnings Per Share A reconciliation of the numerator and denominator of basic and diluted earnings per share is shown below (in thousands, except per share amounts):
|  | For the three months ended |  | For the nine months ended
|  | December 31, |  | December 31,
|  | 2024 |  | 2023 |  | 2024 |  | 2023
Basic earnings per share: |  |  |  |  |  |  |  |
Net earnings from continuing operations |  | $ | 9,522 |  |  | $ | 13,379 |  |  | $ | 3,765 |  |  | $ | 16,269 |
Earnings from discontinued operations, net of tax |  | 1,688 |  |  | 598 |  |  | 1,688 |  |  | 985 |
Net earnings |  | $ | 11,210 |  |  | $ | 13,977 |  |  | $ | 5,453 |  |  | $ | 17,254 |
Basic weighted-average shares outstanding |  | 65,631 |  |  | 65,961 |  |  | 66,182 |  |  | 66,247 |
Continuing operations |  | $ | 0.15 |  |  | $ | 0.20 |  |  | $ | 0.06 |  |  | $ | 0.25 |
Discontinued operations |  | 0.03 |  |  | 0.01 |  |  | 0.03 |  |  | 0.01 |
Basic earnings per share: |  | $ | 0.17 |  |  | $ | 0.21 |  |  | $ | 0.08 |  |  | $ | 0.26 |
Diluted earnings per share: |  |  |  |  |  |  |  |
Basic weighted-average shares outstanding |  | 65,631 |  |  | 65,961 |  |  | 66,182 |  |  | 66,247 |
Dilutive effect of common stock options and restricted stock units as computed under the treasury stock method |  | 1,112 |  |  | 1,982 |  |  | 1,323 |  |  | 1,486 |
Diluted weighted-average shares outstanding |  | 66,743 |  |  | 67,943 |  |  | 67,505 |  |  | 67,733 |
Continuing operations |  | $ | 0.14 |  |  | $ | 0.20 |  |  | $ | 0.06 |  |  | $ | 0.24 |
Discontinued operations |  | 0.03 |  |  | 0.01 |  |  | 0.03 |  |  | 0.01 |
Diluted earnings per share: |  | $ | 0.17 |  |  | $ | 0.21 |  |  | $ | 0.08 |  |  | $ | 0.25 |
Anti-dilutive equity awards under stock-based award plans excluded from the determination of diluted earnings per share |  | 826 |  |  | 1,046 |  |  | 2,166 |  |  | 1,065 |
Earnings per share totals may not sum due to rounding. |  |  |  |
Stockholders’ Equity On August 14, 2024, the Company's board of directors approved an amendment to the existing common stock repurchase program, which was initially adopted in 2011. The amendment authorized an additional $200.0 million in share repurchases, increasing the total amount authorized for repurchase under the common stock repurchase program to $1.3 billion. In addition, it extended the common stock repurchase program duration through December 31, 2026. During the nine months ended December 31, 2024, the Company repurchased 2.8 million shares of its common stock for $75.7 million under the modified common stock repurchase program. Through December 31, 2024, the Company had repurchased a total of 40.5 million shares of its common stock for $1.0 billion under the program, leaving remaining capacity of $281.6 million. The repurchase amounts included in the condensed consolidated statements of stockholders' equity include immaterial amounts related to the 1% excise tax on share repurchases, net of share issuances, as a result of the Inflation Reduction Act of 2022 ("IRA"). Accumulated other comprehensive income balances of $3.5 million and $4.0 million at December 31, 2024 and March 31, 2024, respectively, reflect accumulated foreign currency translation adjustments.

X
- References No definition available. + Details
Name: | ramp_EarningsPerShareAndStockholdersEquityDisclosureTextBlock
Namespace Prefix: | ramp_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ramp_LOSSPERSHAREANDSTOCKHOLDERSEQUITYAbstract
Namespace Prefix: | ramp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration